Healthcare >> CEO Interviews >> August 28, 2013

Interview with the President and CEO: Aeolus Pharmaceuticals, Inc. (AOLS)

McManus, John L.
John L. McManus began as a consultant to Aeolus Pharmaceuticals, Inc., in June 2005, and he became employed as the company’s President and Chief Operating Officer in July 2006, and was appointed President and Chief Executive Officer in March 2007. Mr. McManus, who received his degree in business administration from the University of Southern California in 1986, is the Founder and President of McManus Financial Consultants, Inc., MFC, which provides strategic, financial and investor relations advice to senior managements and boards of directors of public companies, including advice on mergers and acquisitions. These companies have a combined value of over $25 billion. He has served as president of MFC since 1997. In addition, Mr. McManus previously served as Vice President, Finance and Strategic Planning to Spectrum Pharmaceuticals, Inc., where he had primary responsibility for restructuring the company’s operations and finances, including the design of strategic and financial plans to enhance the company’s corporate focus, and leading the successful implementation of these plans. The implementation of these plans led to an increase in Spectrum Pharmaceuticals, Inc.’s market value from $1 million to more than $125 million at the time of Mr. McManus’ departure. Profile
TWST: Tell us about Aeolus Pharmaceuticals. 

Mr. McManus: Aeolus Pharmaceuticals is a biotechnology company that has a platform of catalytic antioxidants that were developed